Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...
Patients with a moderate gastrointestinal risk (one or two risk factors) should receive a COX2 inhibitor or an NSAID plus a PPI or misoprostol. Patients with more than two gastrointestinal risk ...
studies have shown that 25–42% of patients treated with a standard-dose PPI continue to experience symptoms of GERD, such as heartburn, acid regurgitation and dysphagia. As acupuncture has shown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback